One of Clinical.ly’s founding principles is presented up front, as our mission statement: Clinical Trial Software That Puts You in Control. Since our inception, we have been singularly focused on delivering the best possible solutions to the clinical research industry. Today, we are proud to report the incredible growth in studies started on our eRegBinder platform. Since launching eRegBinder, we have experienced consistent quarterly growth of over 60% in new studies started each quarter.
We are forever grateful and indebted to our partners, customers, employees, and everyone who utilizes eRegBinder. Your invaluable feedback helps us continue advancing the platform, thereby ensuring that it fulfills the diverse needs of research sites.
Please contact us if you would like to learn more about how we can help address your regulatory challenges, and improve operational efficiencies.